WearLinq eWave Patch Study
WearLinq eWave Patch Study
This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.
Once eligibility is determined, participants will receive and apply the WearLinq patch for 7 consecutive days (or until an endpoint is met). A subset of subjects will be asked to participate in an Extended Use Cohort (30 days).
Inclusion Criteria:
Exclusion Criteria:
abrown@abioclinical.com408-881-2611
chris@wearlinq.com